Headache and Cortisol Responses to M-Chlorophenylpiperazine are Highly Correlated
- 1 December 1993
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 13 (6) , 400-405
- https://doi.org/10.1046/j.1468-2982.1993.1306400.x
Abstract
The serotonin receptor agonist m-chlorophenylpiperazine (m-CPP) stimulates the release of cortisol and prolactin, and induces migraine-like headaches. We have studied the neuroendocrine and headache responses to m-CPP in 8 subjects with migraine and I0 normal subjects. Each subject underwent two challenge tests, one with 0.25 mg/kg PO of m-CPP and the other with placebo, administered in a double-blind crossover format. Serial measurements of serum cortisol, prolactin, and m-CPP levels were made at 30-min intervals for 210 min following ingestion of the medication. The incidence and severity of headache was assessed by a structured telephone interview after each test. We confirmed that m-CPP stimulates the release of cortisol and prolactin, and may induce headache, in both migraine subjects and normal controls. The cortisol response as well as ratings of headache severity and duration directly correlated with plasma levels of m-CPP. There were highly significant associations between the cortisol response and both headache severity and duration, independent of m-CPP plasma levels. We did not find statistically significant differences between the migraine and normal subjects in terms of their neuroendocrine or headache responses to m-CPP.Keywords
This publication has 19 references indexed in Scilit:
- 1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brainBiological Psychiatry, 1989
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- Serotonin function in anxietyPsychopharmacology, 1987
- Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: Evidence for a serotonin receptor mediated mechanism of action in humansPsychopharmacology, 1986
- Neuroendocrine Effects ofM-Chlorophenylpiperazine, a Serotonin Agonist, in HumansJournal of Clinical Endocrinology & Metabolism, 1985
- Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeysLife Sciences, 1983
- (—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodoneJournal of Pharmacy and Pharmacology, 1981
- Disposition and pharmacological effects of m-Chlorophenylpiperazine in ratsNeuropharmacology, 1981
- Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in ratsNeurochemistry International, 1981
- HEADACHE AS POSSIBLE EXPRESSION OF DEFICIENCY OF BRAIN 5-HYDROXYTRYPTAMINE (CENTRAL DENERVATION SUPERSENSITIVITY)Headache: The Journal of Head and Face Pain, 1972